Oxidants, antioxidants and the pathogenesis of emphysema.

Oxidants, antioxidants and the pathogenesis of emphysema. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Oxidants, antioxidants and the pathogenesis of emphysema. Abstract Text:

A Cantin,R G Crystal,

Emphysema is a chronic pulmonary disorder characterized by a permanent enlargement of the air spaces distal to the terminal bronchioles consequent to destruction of the alveolar walls, including the epithelial and endothelial cells and the connective tissue matrix. There is increasing evidence that an imbalance of oxidants and antioxidants in the lower respiratory tract contributes to this process. Oxidants such as O2-., H2O2, OH, OCl- are generated in the lower respiratory tract as a result of normal biochemical processes, activation of inflammatory cells and inhaled toxic gases. Under normal circumstances, the parenchymal cells are protected by intracellular antioxidants and membrane radical scavengers. In addition, the fluid lining the epithelial surface contains a catalase-like antioxidant that protects the epithelial cells from oxidants. If the oxidant burden overcomes these defenses, the parenchymal cells may be injured, the connective tissue matrix may be partially degraded, the antiprotease screen that protects the lower respiratory tract from attack by neutrophil elastase may be rendered impotent. The alveolar wall then becomes highly vulnerable to elastolytic attack, with a complete destruction of the interstitial connective tissue matrix. In this regard, it is reasonable to hypothesize that reestablishment of the oxidant-antioxidant balance in favor of the antioxidants would be useful as a therapeutic strategy to suppress the emphysematous process.

Oxidants, antioxidants and the pathogenesis of emphysema. Publishing Authors By Initials

A Cantin,RG Crystal,

For similar skin and connective tissue diseases: connective tissue diseases: alpha 1-antitrypsin deficiency research abstracts see: skin and connective tissue diseases: connective tissue diseases: alpha 1-antitrypsin deficiency research

PUBMED ID PMID:

MEDLINE DATE:

Oxidants, antioxidants and the pathogenesis of emphysema. Journal Published:

PUBLICATION TYPE: Review

Journal: European journal of respiratory diseases. Suppleme

VOLUME: 139

Page Numbers: 7-17

Journal Abbreviation:

ISSN: 0106-4347

DAY: 21

MONTH: 02

YEAR: 1985

Oxidants, antioxidants and the pathogenesis of emphysema. Information

Number of References: 77

LANGUAGE: eng

NlmUniqueID: 8010618

Oxidants, antioxidants and the pathogenesis of emphysema. Keywords Mesh Terms:

KEYWORDS: alpha 1-Antitrypsin Deficiency

MESH TERMS: adverse effects

Chemical & Substance for Abstract: Oxidants, antioxidants and the pathogenesis of emphysema. Information

Substance Name: Pancreatic Elastase

Registry Number: EC 3.4.21.36

Grant and Affiliation Information for Oxidants, antioxidants and the pathogenesis of emphysema.

AFFILIATION:

Country: DENMARK

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Eur J Respir Dis Suppl

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Oxidants, antioxidants and the pathogenesis of emphysema Related Publications

• A clinicopathological study of rest tremors in the elderly.
• Ablation of tumor-derived stem cells transplanted to the central nervous system by genetic modification of embryonic stem cells with a suicide gene.
• Adjunct sonography and not screening in cancer detection.
• Antidepressant Treatment and Adherence to Combination Antiretroviral Therapy among Patients with AIDS and Diagnosed Depression.
• Association of comorbidity with physical disability in older HIV-infected adults.
• Chronic treatment with insulin-like growth factor I enhances myocyte contraction by upregulation of Akt-SERCA2a signaling pathway.
• Determinants of Pacemaker Dependency After Coronary and/or Mitral or Aortic Valve Surgery With Long-Term Follow-Up.
• Enhanced Survival of the LINCL Mouse Following CLN2 Gene Transfer Using the rh.10 Rhesus Macaque-derived Adeno-associated Virus Vector.
• Gene delivery of the murine equivalent of bevacizumab (avastin), an anti-vascular endothelial growth factor monoclonal antibody, to suppress growth of human tumors in immunodeficient mice.
• Genetic medicine strategies to protect against bioterrorism.
• Intracellular trafficking of adenovirus: many means to many ends.
• Long-term adherence to evidence based secondary prevention therapies after acute myocardial infarction.
• Metacognition in the rat.
• Modification of gene expression of the small airway epithelium in response to cigarette smoking.
• Neurological deterioration in late infantile neuronal ceroid lipofuscinosis.
• Oxidants, antioxidants and the pathogenesis of emphysema.
• Prevalence and treatment of diagnosed depression among elderly nursing home residents in Ohio.
• Progress and prospects: gene therapy for performance and appearance enhancement.
• Protective immunity against respiratory tract challenge with Yersinia pestis in mice immunized with an adenovirus-based vaccine vector expressing V antigen.
• Protective immunity to pseudomonas aeruginosa induced with a capsid-modified adenovirus expressing P. aeruginosa OprF.
• Responses of the human airway epithelium transcriptome to in vivo injury.
• Scrape biopsy of malignant biliary stricture: what advantage does the new technique offer?
• Survival advantage of neonatal CNS gene transfer for late infantile neuronal ceroid lipofuscinosis.
• Temporal discrimination of alternate days in rats.
• The Gordon Wilson Lecture. In vivo gene therapy: a strategy to use human genes as therapeutics.
• The gordon Wilson lecture: using genetic medicine to regenerate diseased organs and protect against the hostile environment.
• The operable cardiac anomalies.
• Up-regulation of expression of the ubiquitin carboxyl-terminal hydrolase L1 gene in human airway epithelium of cigarette smokers.
• Upregulation of pirin expression by chronic cigarette smoking is associated with bronchial epithelial cell apoptosis.
• Variability in small airway epithelial gene expression among normal smokers.